Intensity Therapeutics, Inc. INTS
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -66.83%
- 1 year
- -89.70%
- Open
- 3.40
- Prev close
- 3.34
- Mkt cap
- 11.10M
- Vol
- 16.12K
- Avg vol
- 25.19K
- EPS
- -3.89
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.21
- High
- 3.46
- Forward P/E
- -1.66
- Beta
- 0.00
- Short ratio
- 3.05
- Inst. own
- 12.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.90
- 200-d avg
- 4.10
- 1y target
- 10.00
1M chart
Signals (8)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 28, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
Discussion (4)
Sign in to join the discussion
Who’s an idiot now?! It was so obvious that this study was based on weak fundamentals and unsupported data‼️ bulls, no worries, there’s always another game
Loading up this dip, ez $$$
VICKY HANUKA INTS 2 years ago #3Benchmark Reiterates Speculative Buy on Intensity Therapeutics, Maintains $12 Price Target
Benzinga
·
08/24 08:52
1min
Intensity Therapeutics(INTS.US)
10.091
+152.28%
Benchmark analyst Robert Wasserman reiterates Intensity Therapeutics (NASDAQ:INTS) with a Speculative Buy and maintains $12 price target.
Disclaimer: This content is for informational and educational purposes only and does not constitute
VICKY HANUKA INTS 2 years ago #4Benchmark Reiterates Speculative Buy on Intensity Therapeutics, Maintains $12 Price Target
Benzinga
·
08/24 08:52
1min
Intensity Therapeutics(INTS.US)
10.091
+152.28%
Benchmark analyst Robert Wasserman reiterates Intensity Therapeutics (NASDAQ:INTS) with a Speculative Buy and maintains $12 price target.
Disclaimer: This content is for informational and educational purposes only and does not constitute